Cutler Group LP Acadia Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	BUY	$14.11 - $18.27 $21,165 - $27,405	1,500 New	1,500 $1,000
Q1 2022 Apr 14, 2022	BUY	$20.94 - $27.5 $33,504 - $44,000	1,600 Added 69.57%	3,900 $7,000
Q4 2021 Jan 18, 2022	SELL	$16.79 - $27.09 $297,183 - $479,493	-17,700 Reduced 88.5%	2,300 $4,000
Q1 2021 Apr 26, 2021	BUY	$25.02 - $54.99 $407,826 - $896,337	16,300 Added 440.54%	20,000 $9,000
Q4 2019 Feb 06, 2020	SELL	$36.21 - $51.4 $409,173 - $580,820	-11,300 Reduced 75.33%	3,700 $0
Q3 2019 Oct 28, 2019	SELL	$22.22 - $44.01 $968,792 - $1.92 Million	-43,600 Reduced 74.4%	15,000 $25,000
Q2 2019 Aug 09, 2019	BUY	$23.32 - $28.12 $841,852 - $1.02 Million	36,100 Added 160.44%	58,600 $46,000
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $229,614 - $388,796	14,200 Added 171.08%	22,500 $49,000
Q4 2018 Feb 05, 2019	SELL	$14.32 - $22.92 $64,440 - $103,140	-4,500 Reduced 35.16%	8,300 $53,000
Q3 2018 Nov 07, 2018	BUY	$13.03 - $21.81 $97,725 - $163,575	7,500 Added 141.51%	12,800 $42,000
Q2 2018 Aug 10, 2018	SELL	$15.07 - $22.34 $896,665 - $1.33 Million	-59,500 Reduced 91.82%	5,300 $75,000
Q1 2018 May 11, 2018	BUY	$22.47 - $32.33 $665,112 - $956,968	29,600 Added 84.09%	64,800 $344,000
Q4 2017 Jan 17, 2018	BUY	$26.84 - $39.14 $80,520 - $117,420	3,000 Added 9.32%	35,200 $134,000
Q3 2017 Oct 17, 2017	BUY	$29.49 - $38.37 $949,578 - $1.24 Million	32,200	32,200 $74,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.